2023 annual financial data
Adial Pharmaceuticals 2023 Net margin
Direct answer
Net margin was Not calculable.
Operating income was -6,887,947 USD and net income was -7,001,890 USD.
Operating cash flow was -6,806,809 USD.
Get free Adial Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -6,887,947 USD
- Net income
- -7,001,890 USD
- Operating cash flow
- -6,806,809 USD
Explore related company data
View all 2023 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Adial Pharmaceuticals financial years